We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
976
DELISTED
Hanesbrands
HBI
$17K ﹤0.01%
1,160
RARE icon
977
Ultragenyx Pharmaceutical
RARE
$2.46B
$17K ﹤0.01%
124
-216
-64% -$25.6K
ACAD icon
978
Acadia Pharmaceuticals
ACAD
$4.51B
$16K ﹤0.01%
299
-590
-66% -$29.3K
BBIO icon
979
BridgeBio Pharma
BBIO
$16.4B
$16K ﹤0.01%
231
-466
-67% -$22.5K
ADPT icon
980
Adaptive Biotechnologies
ADPT
$3.61B
$15K ﹤0.01%
257
-466
-64% -$24K
ARWR icon
981
Arrowhead Research
ARWR
$12.1B
$15K ﹤0.01%
193
-388
-67% -$24.8K
FATE icon
982
Fate Therapeutics
FATE
$275M
$15K ﹤0.01%
164
-326
-67% -$20.2K
ALLK
983
DELISTED
Allakos
ALLK
$14K ﹤0.01%
99
-176
-64% -$18.3K
ARGX icon
984
argenx
ARGX
$55.2B
$14K ﹤0.01%
47
-103
-69% -$28.3K
KOD icon
985
Kodiak Sciences
KOD
$2.5B
$14K ﹤0.01%
95
-151
-61% -$16.8K
ZLAB icon
986
Zai Lab
ZLAB
$2.07B
$14K ﹤0.01%
105
-200
-66% -$20.4K
XLRN
987
DELISTED
Acceleron Pharma
XLRN
$14K ﹤0.01%
113
-225
-67% -$26.4K
DINO icon
988
HF Sinclair
DINO
$16.2B
$13K ﹤0.01%
504
IOVA icon
989
Iovance Biotherapeutics
IOVA
$2.04B
$13K ﹤0.01%
276
-543
-66% -$21.6K
NVAX icon
990
Novavax
NVAX
$1.21B
$13K ﹤0.01%
+120
New +$12.8K
OUT icon
991
Outfront Media
OUT
$5.75B
$13K ﹤0.01%
672
UTHR icon
992
United Therapeutics
UTHR
$26.1B
$13K ﹤0.01%
84
-164
-66% -$21.5K
SYNH
993
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$13K ﹤0.01%
196
-390
-67% -$24.3K
BPMC
994
DELISTED
Blueprint Medicines
BPMC
$12K ﹤0.01%
105
-204
-66% -$21.5K
CM icon
995
Canadian Imperial Bank of Commerce
CM
$106B
$12K ﹤0.01%
270
+110
+69% +$4.48K
EXEL icon
996
Exelixis
EXEL
$13.9B
$12K ﹤0.01%
583
-1,164
-67% -$24.4K
FHN icon
997
First Horizon
FHN
$12.2B
$12K ﹤0.01%
945
+620
+191% +$7.26K
TWST icon
998
Twist Bioscience
TWST
$5.32B
$12K ﹤0.01%
85
-148
-64% -$16.4K
CLPR
999
Clipper Realty
CLPR
$46.4M
$11K ﹤0.01%
1,568
FOLD
1000
DELISTED
Amicus Therapeutics
FOLD
$11K ﹤0.01%
490
-948
-66% -$19.4K

Similar funds

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.